Yurttutan, S. Et Al. 2021. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment. INTERNAL AND EMERGENCY MEDICINE , vol.16, no.4 , 1101-1103.

Yurttutan, S., Gullu, U. U., & Ipek, S., (2021). Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment. INTERNAL AND EMERGENCY MEDICINE , vol.16, no.4, 1101-1103.

Yurttutan, Sadik, UFUK UTKU GÜLLÜ, And Sevcan Ipek. "Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment," INTERNAL AND EMERGENCY MEDICINE , vol.16, no.4, 1101-1103, 2021

Yurttutan, Sadik Et Al. "Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment." INTERNAL AND EMERGENCY MEDICINE , vol.16, no.4, pp.1101-1103, 2021

Yurttutan, S. Gullu, U. U. And Ipek, S. (2021) . "Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment." INTERNAL AND EMERGENCY MEDICINE , vol.16, no.4, pp.1101-1103.

@article{article, author={Sadik Yurttutan Et Al. }, title={Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment}, journal={INTERNAL AND EMERGENCY MEDICINE}, year=2021, pages={1101-1103} }